The journal is excited to announce that Dr. Nicholas P. Tatonetti will be taking over the role of Editor-in-Chief from Dr. Marylyn D. Ritchie. Dr. Tatonetti will join Dr. Jason Moore, who will continue his term as Editor-in-Chief. 
Dr. Nicholas Tatonetti is Professor and Vice Chair of Operations in the Department of Computational Biomedicine and Associate Director of Computational Oncology in the Cancer Center at Cedars-Sinai Medical Center. They received a PhD from Stanford University where they focused on the development of novel statistical and computational methods for observational data mining. Over the past 14 years, Dr. Tatonetti has applied these methods to drug safety surveillance and the discovery of dangerous adverse drug effects and has identified and validated previously unknown serious drug-drug interactions. Their lab at Cedars-Sinai is focused on using massive-scale real clinical and molecular data for making robust and validated scientific discoveries, with a particular focus on detecting, explaining, and validating drug effects and drug interactions.  Dr. Tatonetti has published over 150 peer-reviewed scientific publications across medicine, systems biology, machine learning, and bioinformatics. Dr. Tatonetti is passionate about the integration of real-world data (such as those stored in the electronic health records) and high-dimensional biological data (captured using next-generation sequencing, high-throughput screening, and other "omics" technologies) to reimagine and rescale the scientific method. 
BioData Mining has greatly benefited from the expertise and leadership of the current Editors-in-Chief, and we would like to take this opportunity to thank them for their years of service in supporting and developing the journal. As Dr. Ritchie steps down from her role as Editor-in-Chief, we wish her all the best for the future. 
